Redo-TAVR: Essential Concepts, Updated Data and Current Gaps in Evidence

Area of Science:

• Cardiology
• Interventional Cardiology
• Cardiac Surgery

Background:

• Transcatheter aortic valve replacement (TAVR) has significantly evolved for symptomatic severe aortic stenosis (AS).
• Advances in TAVR technology and techniques have improved safety and reduced complications, enabling its use in lower-risk populations.
• The expansion of TAVR to younger, lower-risk patients necessitates strategies for managing future transcatheter heart valve failure.

Purpose of the Study:

• To review the growing importance of Redo-TAVR for structural valve dysfunction (SVD) in lifetime AS management.
• To outline key considerations for selecting appropriate Redo-TAVR candidates.
• To present updated clinical outcomes, complication rates, and identify evidence gaps.

Main Methods:

• Literature review of recent studies and clinical data on Redo-TAVR.
• Analysis of outcomes and complications associated with Redo-TAVR procedures.
• Synthesis of current evidence regarding patient selection and procedural challenges.

Main Results:

• Redo-TAVR is an emerging strategy for managing SVD after initial TAVR.
• Patient selection is critical, with challenges including coronary re-access and obstruction risk.
• Updated data on clinical outcomes and complication rates are presented, highlighting areas for further research.

Conclusions:

• Redo-TAVR is gaining relevance for the lifetime management of AS, particularly for SVD.
• Careful patient selection and awareness of potential complications are essential for successful Redo-TAVR.
• Further research is needed to address current evidence gaps in Redo-TAVR procedures.